Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Medicinas Complementares
Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Virol J ; 9: 310, 2012 Dec 18.
Artigo em Inglês | MEDLINE | ID: mdl-23244491

RESUMO

BACKGROUND: Since rotavirus is one of the leading pathogens that cause severe gastroenteritis and represents a serious threat to human and animal health, researchers have been searching for cheap, safe, and effective anti-rotaviral drugs. There is a widespread of interest in using natural products as antiviral agents, and among them, licorice derived from Glycyrrhiza spp. has exerted antiviral properties against several viruses. In this study, anti-rotaviral efficacy of Glycyrrhiza uralensis extract (GUE) as an effective and cheaper remedy without side-effects was evaluated in colostrums-deprived piglets after induction of rotavirus diarrhea. METHODS: Colostrums-deprived piglets were inoculated with porcine rotavirus K85 (G5P[7]) strain. On the onset of diarrhea, piglets were treated with different concentration of GUE. To evaluate the antiviral efficacy of GUE, fecal consistency score, fecal virus shedding and histological changes of the small intestine, mRNA expression levels of inflammation-related cytokines (IL8, IL10, IFN-ß, IFN-γ and TNF-α), signaling molecules (p38 and JNK), and transcription factor (NFκB) in the small intestine and spleen were determined. RESULTS: Among the dosages (100-400 mg/ml) administrated to animals, 400 mg/ml of GUE cured diarrhea, and markedly improved small intestinal lesion score and fecal virus shedding. mRNA expression levels of inflammation-related cytokines (IL8, IL10, IFN-ß, IFN-γ and TNF-α), signaling molecules (p38 and JNK), and transcription factor (NFκB) in the small intestine and spleen were markedly increased in animals with RVA-induced diarrhea, but dose- dependently decreased in GUE treated animals after RVA-induced diarrhea. CONCLUSIONS: GUE cures rotaviral enteritis by coordinating antiviral and anti-inflammatory effects. Therapy of this herbal medicine can be a viable medication for curing rotaviral enteritis in animals and humans.


Assuntos
Antivirais/farmacologia , Glycyrrhiza uralensis/química , Fitoterapia , Extratos Vegetais/farmacologia , Infecções por Rotavirus/veterinária , Rotavirus/patogenicidade , Doenças dos Suínos/tratamento farmacológico , Animais , Animais Recém-Nascidos/virologia , Anti-Inflamatórios não Esteroides/química , Anti-Inflamatórios não Esteroides/farmacologia , Antivirais/química , Antivirais/isolamento & purificação , Linhagem Celular , Colostro/metabolismo , Diarreia/tratamento farmacológico , Diarreia/veterinária , Diarreia/virologia , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Fezes/virologia , Interleucina-8/metabolismo , Intestino Delgado/patologia , Intestino Delgado/virologia , Sistema de Sinalização das MAP Quinases , Modelos Animais , NF-kappa B/metabolismo , Extratos Vegetais/química , Raízes de Plantas/química , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Rotavirus/genética , Infecções por Rotavirus/tratamento farmacológico , Infecções por Rotavirus/virologia , Baço/patologia , Baço/virologia , Suínos/virologia , Doenças dos Suínos/virologia , Fator de Necrose Tumoral alfa/metabolismo , Eliminação de Partículas Virais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA